Question Period Notes
About this information
In accordance with the Access to Information Act, the government proactively publishes the package of question period notes that were prepared by a government institution for the minister and that were in use on the last sitting day in June and December.
The question period notes may be partially or fully redacted in accordance with the legislation; for example, if the notes contain information related to national security or personal information. (Learn more about exemptions and exclusions.)
If you find a question period note of interest, you may make an access to information request in order to obtain it.
On November 2, 2023, the National Post published an article that raised questions about the transparency of contract costs related to an item in the Public Health Agency of Canada’s 2022-2023 public accounts. After PSPC obtained permission from the company to release commercial confidential information, the Minister of Health confirmed on November 4, 2023, that a $150 million loss as reported was for a non-refundable advance payment made to Medicago as per the COVID-19 vaccine advance purchase agreement.
On December 8, 2023, it was reported that the Government of Canada reached an agreement with Mitsubishi Chemical Group (MCG) regarding Medicago’s obligations to the Strategic Innovation Fund. The agreement between the Government of Canada and MCG recovers a $40 million payment owed to Canada in relation to the construction of the biomanufacturing facility. The $40 million repayment is not related to the COVID-19 advance purchase agreement.
Notes:
- All questions regarding the regulatory review of vaccines should be directed to Health Canada
- All vaccine and therapeutic health-related questions and questions about allocation and distribution should be directed to Public Health Agency of Canada
- All questions regarding the domestic manufacturing of vaccines and Strategic Innovation Funding investments should be directed to Innovation, Science and Economic Development Canada
- All questions regarding the regulatory review of vaccines should be directed to Health Canada and Public Health Agency of Canada
- All questions regarding Medicago’s organization and the decision to cease Medicago operations in Canada should be directed to the Mitsubishi Chemical Group
- All questions regarding vaccine expiration should be directed to the Public Health Agency of Canada
In 2022-23, what results has Innovation, Science and Economic Development Canada (ISED) achieved for Canadians to support the ongoing recovery of Canada’s tourism sector and contribute to making Canada a leader in the global tourism economy?
The RCMP has asked the court for permission to dispose of 14,000 pieces of evidence collected during its probe into former Port Coquitlam pig farmer Robert (Willie) Pickton.
On December 8, 2023 CBC Canada published an article outlining human smuggling operations along the Canada U.S border.
Ransomware poses a significant cyber threat to our national security, economic prosperity and the personal safety of Canadians.
International students have been impacted by processing delays due to a major increase in the volume of applications. There have also been recent media reports on student vulnerability and housing shortages, sparking concerns.
The Bureau is reporting on China’s foreign interference in the 2021 election based on information received from a CSIS intelligence report marked “Canadian Eyes Only”.
This note focuses on efforts and progress to date to provide support to employees and stabilize the administration of pay, and on financial investments in Phoenix.
Notes:
- All questions related to the mental health of public servants, collective agreements and compensation for Phoenix damages agreements should be directed to the President of the Treasury Board
- Issues related to income tax are under the purview of the Canada Revenue Agency
This note focuses on the efforts and progress to stabilize the administration of pay, manage intake of pay transactions, and the ongoing reduction of the backlog.
Note:
All questions related to Next Generation Human Resources and Pay solution are in a separate question period card developed by Shared Services Canada
Results of the 2023 CSELCC in the provinces and 2023 SELCCA in the territories are released by Statistics Canada on December 5, 2023